Hasta la próxima

Auto reproducción

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 vistas • 07/04/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción